Lotus Pharmaceutical Co Ltd
TWSE:1795
Wall Street
Price Targets
Price Targets Summary
Lotus Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Lotus Pharmaceutical Co Ltd
is 442 TWD
with a low forecast of 323.2 TWD and a high forecast of 630 TWD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Lotus Pharmaceutical Co Ltd
For the last 8 years the
compound annual growth rate for
Lotus Pharmaceutical Co Ltd's operating income is
35%.
The projected
CAGR
for the next 2 years is
27%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Lotus Pharmaceutical Co Ltd's stock price target?
Price Target
442
TWD
According to Wall Street analysts, the average 1-year price target for
Lotus Pharmaceutical Co Ltd
is 442 TWD
with a low forecast of 323.2 TWD and a high forecast of 630 TWD.
What is Lotus Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Lotus Pharmaceutical Co Ltd's revenue is
15%.
The projected
CAGR
for the next 2 years is
16%.
What is Lotus Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
27%
For the last 8 years the
compound annual growth rate for
Lotus Pharmaceutical Co Ltd's operating income is
35%.
The projected
CAGR
for the next 2 years is
27%.
What is Lotus Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Lotus Pharmaceutical Co Ltd's net income is
58%.
The projected
CAGR
for the next 2 years is
21%.
You don't have any saved screeners yet
